Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cisplatin Based Regimen to Patients With Advanced Pancreatic Cancer and Homologous Recombination Deficiency

NCT06095141 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT06095141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06095141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cisplatin Based Regimen to Patients With Advanced Pancreatic Cancer and Homologous Recombination Deficiency
Lead sponsor
Fudan University
Phase
Phase 2/3
Overall status
Recruiting
Start date
December 1, 2023
Completion date
October 31, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

homologous recombination deficiency, pancreatic adenocarcinoma